Ribosomopathies: Mechanisms of Disease

Ribosomopathies: Mechanisms of Disease

Show other versions (1)

Bibliographic Details
Main Authors:	Hani Nakhoul, Jiangwei Ke, Xiang Zhou, Wenjuan Liao, Shelya X. Zeng, Hua Lu
Format:	Article
Language:	English
Published:	SAGE Publishing 2014-08-01
Series:	Clinical Medicine Insights: Blood Disorders
Online Access:	http://www.la-press.com/ribosomopathies-mechanisms-of-disease-article-a4338

Similar Items

Ribosomopathies: Mechanisms of Disease
by: Hani Nakhoul, et al.
Published: (2014-01-01)

HMG-boxes, ribosomopathies and neurodegenerative disease
by: Tom Moss, et al.
Published: (2023-08-01)

Cancer Biogenesis in Ribosomopathies
by: Sergey O. Sulima, et al.
Published: (2019-03-01)

Ribosomopathies: New Therapeutic Perspectives
by: Emilien Orgebin, et al.
Published: (2020-09-01)

Ribosomopathy-like properties of murine and human cancers.
by: Sucheta Kulkarni, et al.
Published: (2017-01-01)

Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
by: Mengxin Wang, et al.
Published: (2024-03-01)

Editorial: Inherited and acquired ribosomopathies: missing puzzle pieces
by: Roberto Valli, et al.
Published: (2023-04-01)

Convergent somatic evolution commences in utero in a germline ribosomopathy
by: Heather E. Machado, et al.
Published: (2023-08-01)

Nucleolar stress in Drosophila neuroblasts, a model for human ribosomopathies
by: Sonu Shrestha Baral, et al.
Published: (2020-04-01)

Structural Abnormalities in the Hair of a Patient with a Novel Ribosomopathy.
by: Richard J Alsop, et al.
Published: (2016-01-01)

Rpsamutations in isolated congenital asplenia (ICA): A ribosomopathy unveiled
by: Bosch, B, et al.
Published: (2017)

How Altered Ribosome Production Can Cause or Contribute to Human Disease: The Spectrum of Ribosomopathies
by: Giulia Venturi, et al.
Published: (2020-10-01)

A ribosomopathy reveals decoding defective ribosomes driving human dysmorphism.
by: Paolini, N, et al.
Published: (2017)

Mutations in Hcfc1 and Ronin result in an inborn error of cobalamin metabolism and ribosomopathy
by: Tiffany Chern, et al.
Published: (2022-01-01)

Invariable Ribosome Stoichiometry During Murine Erythroid Differentiation: Implications for Understanding Ribosomopathies
by: Christos I. Papagiannopoulos, et al.
Published: (2022-02-01)

Ribosomopathies: how a common root can cause a tree of pathologies
by: Nadia Danilova, et al.
Published: (2015-09-01)

Global effect of inauhzin on human p53-responsive transcriptome.
by: Jun-Ming Liao, et al.
Published: (2012-01-01)

Impaired phase separation and nucleolar functions in hiPSC models of SNORD118-related ribosomopathies
by: Wei Zhang, et al.
Published: (2024-08-01)

GATA1 and PU.1 Bind to Ribosomal Protein Genes in Erythroid Cells: Implications for Ribosomopathies.
by: Elsa P Amanatiadou, et al.
Published: (2015-01-01)

A novel mouse model provides insights into the neutropenia associated with the ribosomopathy Shwachman-Diamond syndrome
by: Kim De Keersmaecker
Published: (2015-10-01)

The Nucleolus: A Multiphase Condensate Balancing Ribosome Synthesis and Translational Capacity in Health, Aging and Ribosomopathies
by: Carl C. Correll, et al.
Published: (2019-08-01)

Novel RPL13 variants and evidence for incomplete penetrance in a human ribosomopathy with spondyloepimetaphyseal dysplasia
by: Alice Costantini, et al.
Published: (2020-10-01)

Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
by: Boultwood, J, et al.
Published: (2013)

Determination of maximum tolerated dose and toxicity of Inauhzin in mice
by: Qi Zhang, et al.
Published: (2015-01-01)

A trans locus causes a ribosomopathy in hypertrophic hearts that affects mRNA translation in a protein length-dependent fashion
by: Franziska Witte, et al.
Published: (2021-06-01)

Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
by: Ibrahim Taha, et al.
Published: (2022-08-01)

RBM10, a New Regulator of p53
by: Ji Hoon Jung, et al.
Published: (2020-09-01)

p53 induces ARTS to promote mitochondrial apoptosis
by: Qian Hao, et al.
Published: (2021-02-01)

Inauhzin Sensitizes p53-Dependent Cytotoxicity and Tumor Suppression of Chemotherapeutic Agents
by: Yiwei Zhang, et al.
Published: (2013-05-01)

The role of IMP dehydrogenase 2 in Inauhzin-induced ribosomal stress
by: Qi Zhang, et al.
Published: (2014-10-01)

Pleckstrin homology domain-containing protein PHLDB3 supports cancer growth via a negative feedback loop involving p53
by: Tengfei Chao, et al.
Published: (2016-12-01)

Structure and activity analysis of Inauhzin analogs as novel antitumor compounds that induce p53 and inhibit cell growth.
by: Qi Zhang, et al.
Published: (2012-01-01)

Inactivation of oncogenic cAMP-specific phosphodiesterase 4D by miR-139-5p in response to p53 activation
by: Bo Cao, et al.
Published: (2016-07-01)

Hepatic ribosomal protein S6 (Rps6) insufficiency results in failed bile duct development and loss of hepatocyte viability; a ribosomopathy-like phenotype that is partially p53-dependent.
by: Sarah A Comerford, et al.
Published: (2023-01-01)

KEGIATAN PRESERVASI DI PERPUSTAKAAN FAKULTAS ILMU BUDAYA UNIVERSITAS PADJADJARAN
by: Angeli Shelya Noviyanti
Published: (2023-06-01)

Nerve growth factor receptor negates the tumor suppressor p53 as a feedback regulator
by: Xiang Zhou, et al.
Published: (2016-06-01)

3253 Identification of Immune Cell Profiles and Molecular Pathways in Inflammatory Bowel Disease Driving Non-Response to Biologic Therapy
by: Harrison Michael Penrose, et al.
Published: (2019-03-01)

The shortest species: how the length of Russian poetry changed (1750–1921)
by: Artjom Shelya, et al.
Published: (2017-08-01)

Ccdc3: A New P63 Target Involved in Regulation Of Liver Lipid Metabolism
by: Wenjuan Liao, et al.
Published: (2017-08-01)

Chat GPT 4o vs residents: French language evaluation in ophthalmology
by: Leah Attal, et al.
Published: (2025-04-01)